SavedAdd your journal

Journals / Glokom Katarakt / 2011 / Cilt: 6 - Sayı: 1

The assessement of health related quality of life in glaucoma patients

Glokom hastalarında sağlıkla ilişkili yaşam kalitesinin değerlendirilmesi

Olcayto ÇELİK
Gül ARIKAN
Üzeyir GÜNENÇ
Güray ÇINGIL
Pages
25–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Esterman test correlated well with the overall Modified Glau-QOL 17 score (PCC=0.41; p=0.001) but only moderately with the time trade-off test (PCC=0.20; p=0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the relationship between clinical measures of visual function and quality of life in glaucoma patients.
📊
Key Findings & Data:Materials and Methods: Ninety primary open angle glaucoma patients were evaluated with using one utility test, the time trade-off test and one quality of life instrument, Modified Glau-QOL 17 Questionnaire.
💡
Conclusion & Impact:The Esterman test correlated well with the overall Modified Glau-QOL 17 score (PCC=0.41; p=0.001) but only moderately with the time trade-off test (PCC=0.20; p=0.05).
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the relationship between clinical measures of visual function and quality of life in glaucoma patients. Materials and Methods: Ninety primary open angle glaucoma patients were evaluated with using one utility test, the time trade-off test and one quality of life instrument, Modified Glau-QOL 17 Questionnaire. Their results were compared to Esterman binocular visual field (BVF) and other clinical test of their visual function. Results: The mean score for the Modified Glau-QOL 17 Questionnaire was 77.6±12.4 (38.7-98.2) and 94.1±6.4 (69-100) for the Esterman BVF. The Esterman test correlated well with the overall Modified Glau-QOL 17 score (PCC=0.41; p=0.001) but only moderately with the time trade-off test (PCC=0.20; p=0.05). In addition, C/D ratio in the worse eye (PCC=-0.29; p=0.006), GSS 2 stage in the better eye (PCC=-0.27; p=0.01), glaucoma duration in years (PCC=0.23; p=0.03) and PSD in the better eye (PCC=-0.22; p=0.03) were correlated moderately with overall Modified Glau-QOL 17 score. Correlation between the time trade-off test and the overall Modified Glau-QOL 17 score was moderate (PCC=-0.32; p=0.002). Conclusion: Time trade-off utility test do not correlate well with the Esterman test results and other clinical test of visual function than Modified Glau-QOL 17 questionnaire

Özet

Amaç: Glokom hastalarında görme fonksiyonunun klinik ölçüm ve testleri ile yaşam kalitesi arasındaki ilişkiyi değerlendirmek. Gereç ve Yöntem: Doksan primer açık açılı glokom hastası fayda testlerinden zaman değiş-tokuşu (ZDT) ve yaşam kalitesi enstrümanlarından Modifiye Glau-QOL 17 anketi kullanılarak değerlendirildi. Sonuçlar Esterman binoküler görme alanı (BGA) ve diğer klinik ölçüm ve test sonuçları ile karşılaştırıldı. Bulgular: Modifiye Glau-QOL 17 anketi ortalama genel puanı 77.6±12.4 (38.7-98.2) ve Esterman BGA ortalama puanı 94.1±6.4 (69-100) olarak bulundu. Esterman BGA sonuçları Modifiye Glau-QOL 17 anketi ile iyi derecede bir bağıntı (PCC=0.41; p=0.001) sergilerken, ZDT sonuçları ile arasında orta seviyede bir ilgileşim (PCC=0.20; p=0.05) olduğu görüldü. Buna ek olarak kötü göz C/D oranı (PCC=-0.29; p=0.006), iyi göz GSS 2 evresi (PCC=-0.27; p=0.01), yıl olarak glokom süresi (PCC=0.23; p=0.03) ve iyi göz PSD değeri (PCC=-0.22; p=0.03) ile Modifiye Glau-QOL 17 anketi genel puanı arasında orta dereceli bağıntılar bulundu. ZDT sonuçları ve Modifiye Glau-QOL 17 anketi genel puanı arasındaki ilgileşim (PCC=-0.32; p=0.002) orta seviyedendi. Sonuç: Glokom hastalarında yaşam kalitesinin değerlendirilmesinde ZDT yöntemi, Esterman BGA testi ve diğer görme fonksiyonu test ve ölçümleri ile Modifiye Glau-QOL 17 anketi ile karşılaştırıldığında iyi bir korelasyon göstermemiştir

🔖

Cite This Article

ÇELİK, O., ARIKAN, G., GÜNENÇ, Ü., ÇINGIL, G. (2011). The assessement of health related quality of life in glaucoma patients. Glokom Katarakt, Cilt: 6 - Sayı: 1, 25–31. https://ajindex.com/articles/226829

References (15)

  1. Altangerel U, Spaeth GL, Rhee DJ.: Visual function, disability, and psychological impact of glaucoma. Curr Opin Ophthalmol. 2003;14:100-105
  2. Coleman AL, Stone K, Ewing SK, et al.: Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology. 2004;111:857-862
  3. McGwin G Jr, Owsley C, Ball K.: Identifying crash involvement among older drivers: agreement between self-report and state records. Accid Anal Prev. 1998;30:781-791
  4. Brusini P, Filacorda S.: Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. J Glaucoma. 2006;15:40-46
  5. Rouland JF, Denis P, Béchetoille A, et al.: Creating a specific quality-of-life questionnaire in patients with glaucoma: item generation. J Fr Ophtalmol. 2002;25:785-794
  6. Mills RP, Janz NK, Wren PA, et al.: Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001;10:192-198
  7. Janz NK, Wren PA, Lichter PR, et al.: Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001; 108:887-897. 8. 8.Wilson MR, Coleman AL, Yu F, et al.: Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105:2112-2116
  8. Parrish RK 2nd, Gedde SJ, Scott IU, et al.: Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447-1455
  9. Jampel HD, Schwartz A, Pollack I, et al.: Glaucoma patients’ assessment of their visual function and quality of life. J Glaucoma. 2002;11:154-163
  10. Cumurcu BE, Cumurcu T, Çelikel FÇ, et al.: The relation between quality of life and visual functioning in patients with glaucoma. Turkiye Klinikleri J Med Sci. 2010;30:698-704
  11. Gutierrez P, Wilson MR, Johnson C, et al.: Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784
  12. Iester M, Zingirian M.: Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16:44-49
  13. Viswanathan AC, McNaught AI, Poinoosawmy D, et al.: Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999;117:450-454
  14. Nelson P, Aspinall P, O’Brien C.: Patients’ perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999;83: 546-552
  15. Elson P, Aspinall P, Papasouliotis O,